Bicycle Therapeutics - Stock Price History | BCYC

Historical daily share price chart and data for Bicycle Therapeutics since 2021 adjusted for splits. The latest closing stock price for Bicycle Therapeutics as of September 23, 2021 is 43.50.
  • The all-time high Bicycle Therapeutics stock closing price was 44.24 on September 16, 2021.
  • The Bicycle Therapeutics 52-week high stock price is 45.21, which is 3.9% above the current share price.
  • The Bicycle Therapeutics 52-week low stock price is 17.68, which is 59.4% below the current share price.
  • The average Bicycle Therapeutics stock price for the last 52 weeks is 27.21.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Bicycle Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 16.3022 9.8200 21.3600 9.8200 17.9500 90.35%
2019 9.3683 12.0000 14.6300 6.7360 9.4300 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.104B $0.010B
Bicycle Therapeutics plc is a clinical-stage biopharmaceutical company. It is focused on developing medicines, referred to as Bicycles(R) for diseases which are underserved by existing therapeutics. Bicycle Therapeutics plc is based in Cambridge, United Kingdom.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $133.660B 8.90
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.482B 21.14
Biohaven Pharmaceutical Holding (BHVN) United States $8.764B 0.00
Emergent Biosolutions (EBS) United States $2.892B 6.98
Arcus Biosciences (RCUS) United States $2.573B 0.00
Myovant Sciences (MYOV) United Kingdom $2.051B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.021B 0.00
Zymeworks (ZYME) Canada $1.443B 0.00
Ambrx Biopharma (AMAM) United States $0.527B 0.00
SQZ Biotechnologies (SQZ) United States $0.417B 0.00
Enzo Biochem (ENZ) United States $0.172B 50.71